IL97008A - An antiviral pharmaceutical preparation for topical use containing penciclovir - Google Patents

An antiviral pharmaceutical preparation for topical use containing penciclovir

Info

Publication number
IL97008A
IL97008A IL9700891A IL9700891A IL97008A IL 97008 A IL97008 A IL 97008A IL 9700891 A IL9700891 A IL 9700891A IL 9700891 A IL9700891 A IL 9700891A IL 97008 A IL97008 A IL 97008A
Authority
IL
Israel
Prior art keywords
penciclovir
pharmaceutical formulation
oil
phase
water
Prior art date
Application number
IL9700891A
Other languages
English (en)
Hebrew (he)
Other versions
IL97008A0 (en
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of IL97008A0 publication Critical patent/IL97008A0/xx
Publication of IL97008A publication Critical patent/IL97008A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9700891A 1990-01-26 1991-01-23 An antiviral pharmaceutical preparation for topical use containing penciclovir IL97008A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909001886A GB9001886D0 (en) 1990-01-26 1990-01-26 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
IL97008A0 IL97008A0 (en) 1992-03-29
IL97008A true IL97008A (en) 1995-05-26

Family

ID=10669997

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9700891A IL97008A (en) 1990-01-26 1991-01-23 An antiviral pharmaceutical preparation for topical use containing penciclovir

Country Status (29)

Country Link
EP (1) EP0511991B1 (zh)
JP (1) JP2545317B2 (zh)
KR (1) KR0170414B1 (zh)
CN (1) CN1056058C (zh)
AP (1) AP197A (zh)
AT (1) ATE142880T1 (zh)
AU (1) AU643975B2 (zh)
CA (1) CA2074503C (zh)
CY (2) CY1984A (zh)
DE (1) DE69122229T2 (zh)
DK (1) DK0511991T3 (zh)
ES (1) ES2092559T3 (zh)
FI (1) FI101600B (zh)
GB (1) GB9001886D0 (zh)
GR (1) GR3021385T3 (zh)
HK (1) HK218996A (zh)
HU (1) HU215842B (zh)
IE (1) IE910249A1 (zh)
IL (1) IL97008A (zh)
LU (1) LU90110I2 (zh)
MA (1) MA22051A1 (zh)
MY (1) MY110074A (zh)
PL (1) PL166678B1 (zh)
PT (1) PT96563B (zh)
SA (1) SA91110341B1 (zh)
SG (1) SG49144A1 (zh)
TW (1) TW307687B (zh)
WO (1) WO1991011187A1 (zh)
ZA (1) ZA91525B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition
US11364198B2 (en) 2018-04-05 2022-06-21 Bausch Health Ireland Limited Polymeric emulsion delivery systems

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0152316B1 (en) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituted butyl guanines and their utilization in antiviral compositions
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.

Also Published As

Publication number Publication date
HU215842B (hu) 2001-02-28
SA91110341B1 (ar) 2004-05-25
KR920703060A (ko) 1992-12-17
FI923371A0 (fi) 1992-07-24
IL97008A0 (en) 1992-03-29
CY1999020I2 (en) 2009-11-04
SG49144A1 (en) 1998-05-18
CN1056058C (zh) 2000-09-06
DE69122229T2 (de) 1997-03-06
MA22051A1 (fr) 1991-10-01
ES2092559T3 (es) 1996-12-01
IE910249A1 (en) 1991-07-31
AU643975B2 (en) 1993-12-02
PT96563B (pt) 1998-07-31
AP9000236A0 (en) 1991-01-31
LU90110I2 (fr) 1997-09-25
DK0511991T3 (da) 1996-11-11
AP197A (en) 1992-06-30
FI923371A (fi) 1992-07-24
EP0511991A1 (en) 1992-11-11
FI101600B1 (fi) 1998-07-31
CA2074503A1 (en) 1991-07-27
PL166678B1 (pl) 1995-06-30
JPH05503695A (ja) 1993-06-17
ATE142880T1 (de) 1996-10-15
CA2074503C (en) 1999-12-14
EP0511991B1 (en) 1996-09-18
FI101600B (fi) 1998-07-31
PT96563A (pt) 1991-10-15
HU9202431D0 (en) 1992-10-28
CN1053547A (zh) 1991-08-07
AU7155891A (en) 1991-08-21
DE69122229D1 (de) 1996-10-24
GB9001886D0 (en) 1990-03-28
WO1991011187A1 (en) 1991-08-08
KR0170414B1 (ko) 1999-02-18
TW307687B (zh) 1997-06-11
MY110074A (en) 1997-12-31
CY1984A (en) 1997-09-05
HUT62472A (en) 1993-05-28
HK218996A (en) 1997-01-03
ZA91525B (en) 1992-02-26
GR3021385T3 (en) 1997-01-31
JP2545317B2 (ja) 1996-10-16

Similar Documents

Publication Publication Date Title
US4661524A (en) Topical treatment and composition
US4963555A (en) Formulations of heterocyclic compounds
KR100303095B1 (ko) 알릴 아민 화합물을 함유하는 국소용 약학 조성물
EP0044543B1 (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
AP197A (en) Pharmaceutical formulations for treatment of virus infections of the skin containing penciclovir.
EP0593562B1 (en) Topical composition containing penciclovir
WO1998010768A1 (en) Antiviral compositions
IE902819A1 (en) Pharmaceutical formulation
US6469015B1 (en) Pharmaceutical formulation
EP4114358A1 (en) Topical pharmaceutical formulations of a cyclic depsipeptide

Legal Events

Date Code Title Description
CB Opposition filed against grant of patent

Free format text: 22.08.95